Research record
Acute lymphoblastic leukemia source map
ALL needs age-aware source handling. Families should separate adult ALL, childhood ALL, AYA care, B-cell versus T-cell wording, and transplant/CAR-T/trial questions.
What this is
ALL needs age-aware source handling. Families should separate adult ALL, childhood ALL, AYA care, B-cell versus T-cell wording, and transplant/CAR-T/trial questions.
Why it may come up
- adult ALL
- childhood ALL
- AYA leukemia
- trial search
What not to assume
- Do not machine-translate pediatric treatment claims into Korean.
At a glance
Acute lymphoblastic leukemia source map
- Type
- diagnostic-context
- Mutation result
- varies by subtype
- Where
- Global
- Evidence status
- Source gives context
- Last checked
- 2026-05-21
What we know
- NCI has dedicated patient summaries for adult ALL and childhood ALL.
- Pediatric leukemia content requires extra care and pediatric source mapping.
What is unclear
- Korean pediatric leukemia source mapping and reviewer workflow are not complete.
Questions to ask
- Does the report say B-cell ALL, T-cell ALL, Philadelphia chromosome positive, or another subtype?
- Is care being handled by adult hematology, pediatric oncology, or an AYA-focused team?
- Are transplant, CAR-T, or trial referral questions relevant to this phase?